TXG Nov 2024 22.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:55PM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
We Think Some Shareholders May Hesitate To Increase 10x Genomics, Inc.'s (NASDAQ:TXG) CEO Compensation
Key Insights 10x Genomics to hold its Annual General Meeting on 11th of June Total pay for CEO Serge Saxonov includes...
- PR Newswire
10x Genomics Launches 5,000-Plex Gene Panel for Xenium
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of its Xenium Prime 5K Pan-Tissue and Pathways panel. The new assay features an enhanced chemistry to increase plex by an order of magnitude while delivering excellent per-gene sensitivity, improved specificity and spatial fidelity, integrated multimodal cell segmentation, and industry-leading speed and throughput.
- Zacks
International Markets and 10x Genomics (TXG): A Deep Dive for Investors
Review 10x Genomics' (TXG) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
© 2024 Yahoo. All rights reserved.